What is Nivolumab?

Category: Prescription Drugs

Most popular types: Opdivo

false

Nivolumab is an injectable medication that works with your body's immune system to fight certain types of cancer. It may be used for the treatment of some types of melanoma and non-small cell lung cancer.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Adenocarcinoma (non-small cell lung cancer) 18 14
Squamous cell carcinoma (non-small cell lung cancer) 7 6
Non-small cell lung cancer 6 5
Metastatic melanoma 2 1
Small cell lung cancer 2 2
Adenosquamous carcinoma (non-small cell lung cancer) 1 1

Show all 11 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 3
Moderate 2
Mild 13
None 11

Commonly reported side effects and conditions associated with Nivolumab

Side effect Patients Percentage
Fatigue 3
Hyperthyroidism 2
Joint pain 2
Muscle and joint pain 2
Blurry vision 1
Chills 1

Show all 30 reported side effects

Dosages

Based on patients currently taking Nivolumab

Dosage Patients Percentage
10 mg every other week 3
240 mg every other week 2
240 intl units every other week 1
480 mg every 3 weeks 1
3470 mg every other week 1

Why patients stopped taking Nivolumab

Multiple reasons could be selected

Reason Patients Percentage
Other 2
Doctor's advice 1
Expense 1
Side effects too severe 1
See all 5 patients who've stopped taking Nivolumab

Duration

Currently taking Nivolumab

Duration Patients Percentage
1 - 2 years 3
2 - 5 years 6

Stopped taking Nivolumab

Duration Patients Percentage
Less than 1 month 1
1 - 6 months 3
1 - 2 years 1
Adherence
Adherence Evaluations Percentage
Always 25
Usually 0
Sometimes 1
Never taken as prescribed 3
Burden
Burden Evaluations Percentage
Very hard to take 1
Somewhat hard to take 4
A little hard to take 5
Not at all hard to take 19
Cost per month
Cost per month Evaluations Percentage
$200+ 5
$100-199 1
$50-99 1
$25-49 0
< $25 7
Not specified 15

What people switch to and from

Patients started taking Nivolumab after stopping:

Treatment Patients Percentage
Chemotherapy 19
Bevacizumab (Avastin) 2
Capecitabine (Xeloda) 1
Carboplatin 1
Oxaliplatin 1

Show all 8 treatments patients report switching from

Patients stopped taking Nivolumab and switched to:

Treatment Patients Percentage
Bevacizumab (Avastin) 1
Everolimus (Afinitor) 1
Ipilimumab (Yervoy) 1
Lenvatinib (Lenvima) 1
Last updated:
There are no evaluations for Nivolumab.